To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure firstname.lastname@example.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The current understanding regarding the therapeutic potential of statins in central nervous system (CNS) autoimmune diseases evolved from studies in mice with experimental autoimmune encephalomyelitis (EAE). Migration of leukocytes from the blood into the CNS involves multiple steps, including chemo-attraction, cell adhesion, extravasation, and proteolytic degradation of biological membranes. Statin-mediated immunomodulation observed in mice may translate to humans. In vitro, statins inhibit the expression of intracellular adhesion molecule (ICAM)-1 and various chemokine receptors on activated peripheral mononuclear cells from both patients with multiple sclerosis (MS) and controls. Although statins are considered safe and well-tolerated drugs, they have side effects that should be considered. Statins have been shown to target key elements of the immunological cascade associated with glial and neural tissue damage in MS. In a recent placebo-controlled trial in patients with early MS, Statin treatment reduced development of newly occurring CNS inflammatory lesions.